4.5 Article

Identification of dual mechanisms mediating 5-hydroxytryptamine receptor 1F-induced mitochondrial biogenesis

Journal

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
Volume 314, Issue 2, Pages F260-F268

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajprenal.00324.2017

Keywords

Akt; G protein-coupled receptor; GPCR; ERK; extracellular signal reaflated kinase; 5-HT; mitochondria; protein kinase B; serotonin

Funding

  1. National Institute of General Medical Sciences [R01-64-084147]
  2. Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs Grain [BX-000851]
  3. National Institute of Diabetes and Digestive and Kidney Diseases Ruth L. Kirschstein National Research Services Award [5T32-DK-083262]

Ask authors/readers for more resources

laboratory recently made the novel observation that 5-hydroxytryptamine 1F (5-11T(IF)) receptor activation induces mitochondria' biogenesis (MB), the production of new, functional mitochondria, in vitro and in vivo. We sought to determine the mechanism linking the 5-HTIF receptor to MB in renal proximal tubule cells. Using LY344864, a selective 5-HT1F flip receptor agonist, we determined that the 5-HT1F receptor is coupled to Guik, and induces MB through G beta gamma-dependent activation of Akt, endothelial nitric oxide synthase (eNOS), cyclic guanosine-monophosphate (cGMP), protein kinase G (PKG), and peroxisome proliferator-activated receptor-gamma coactivator-gamma (PGC-l alpha). We also report that the 5-HT1F, receptor signals through a second, (G beta gamma-dependent pathway that is linked by Akt phosphorylation of Raf. In contrast to the activated Akt pathway, Raf phosphorylation reduced extracellular signal regulated kinases (ERKI/2) and foxhead box 03a (FOX03a) phosphorylation, suppressing an inhibitory MB pathway. These results demonstrate that the 5-HT1F receptor regulates MB through G beta gamma-dependent dual mechanisms that activate a stimulatory MB pathway, Akt/eNOS/cGMP/PKG/PGC-1 alpha, while simultaneously repressing an inhibitory MB pathway, Raf/MEK/ERK/FOXO3a. Novel mechanisms of MB provide the foundation for new chemicals that induce MB to treat acute and chronic organ injuries.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available